Chattanooga, Tenn. – Erlanger Health System has expanded its partnership with Tennessee Oncology to assume provision of medical oncology and hematology care to patients. The expanded partnership provides patients with access to additional resources, clinical trials, therapeutics, and predictive data benefiting treatment and patient outcomes. There will be no lapse in care for current patients. … Continue reading Erlanger expands partnership with Tennessee Oncology
cancer
Erlanger hosts Survivin’ & Thrivin’ Cancer Survivorship Symposium in September
Chattanooga, Tenn. – Erlanger Health System announces registration is now open for the first ever Survivin’ & Thrivin’, a cancer survivorship symposium, to be held on Saturday, September 17, 2022. This inaugural event is designed for women impacted by cancer. Hear from a variety of women’s specialists, including Dr. Beth Snell and Dr. Shae Connor, … Continue reading Erlanger hosts Survivin’ & Thrivin’ Cancer Survivorship Symposium in September
Erlanger Health System and Vanderbilt-Ingram Cancer Center partnership in Cancer Care
Chattanooga, Tenn. – Erlanger Health System and Vanderbilt University Medical Center, on behalf of Vanderbilt-Ingram Cancer Center (VICC), have entered into a professional service agreement designing a long-term collaboration in comprehensive cancer care, including VICC hematology-oncology services at Erlanger Oncology and Hematology and infusion locations. The agreement, which became effective Oct. 1, establishes VICC as … Continue reading Erlanger Health System and Vanderbilt-Ingram Cancer Center partnership in Cancer Care
Erlanger launches risk assessment survey for hereditary cancers
Erlanger Health System’s Center for Breast Health is now offering an online risk assessment tool for mammogram and breast imaging patients. The assessment aims to help determine if a woman may be at higher risk for certain types of cancers due to hereditary risk factors. When patients come in for their appointments, they will be … Continue reading Erlanger launches risk assessment survey for hereditary cancers
Erlanger’s breast health program receives national accreditation
Erlanger Cancer Institute’s breast health program received a three year/full accreditation designation by the National Accreditation Program for Breast Centers (NAPBC), a program administered by the American College of Surgeons. Accreditation by the NAPBC is only given to those centers that have voluntarily committed to provide the highest level of quality breast care and that … Continue reading Erlanger’s breast health program receives national accreditation
Erlanger News 